Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Country / region: Italy Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20081
20101
20111
20122
20142
20161
20183
20192
20206
20213
20224
20236
20243
20257

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting11
Active, not recruiting5
Terminated4
Unknown status2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gruppo Italiano Malattie EMatologiche dell'Adulto7
Novartis Pharmaceuticals6
argenx6
Takeda3
Chugai Pharmaceutical2
GlaxoSmithKline2
Rigel Pharmaceuticals2
UCB Biopharma SRL2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic46
Thrombocytopenia6
Purpura5
Anemia, Hemolytic, Autoimmune4
Hematologic Diseases4
Autoimmune Diseases3
Blood Platelet Disorders3
Hemorrhage3
Hemorrhagic Disorders3
Antiphospholipid Syndrome2

Trials

Showing 51 to 46 of 46. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.